Cargando…

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer

The purpose was to investigate the interrater agreement of FDG-PET/CT and bone scintigraphy for diagnosing bone recurrence in breast cancer patients. A total of 100 women with suspected recurrence of breast cancer underwent planar whole-body bone scintigraphy with [99mTc]DPD and FDG-PET/CT. Scans we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holm, Jorun, Ahangarani Farahani, Ziba, Gerke, Oke, Baun, Christina, Falch, Kirsten, Malene Grubbe, Hildebrandt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760596/ https://www.ncbi.nlm.nih.gov/pubmed/33260766 http://dx.doi.org/10.3390/diagnostics10121021

Ejemplares similares

Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Hansen, Jeanette Ansholm, et al.
Publicado: (2021)

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
por: Sørensen, Jonas S., et al.
Publicado: (2020)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019)

Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis
por: Aarstad, Else Marie, et al.
Publicado: (2019)

2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor—A Retrospective Register-Based Cohort Study
por: Rimer, Heidi, et al.
Publicado: (2023)

Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
por: Vogsen, Marianne, et al.
Publicado: (2021)

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
por: Gerke, Oke, et al.
Publicado: (2017)

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

Introduction to interrater agreement for nominal data
por: Popping, Roel
Publicado: (2019)

Interrater and intrarater agreement on heart murmurs
por: Andersen, Stian, et al.
Publicado: (2023)

Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2020)

The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [(18)F]FDG-PET/CT and CE-CT
por: Gram-Nielsen, Rosa, et al.
Publicado: (2023)

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021)

The Utility of 18F‐FDG PET/CT in Patients With Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross‐sectional Study
por: Emamifar, Amir, et al.
Publicado: (2020)

Clinical presentation and treatment response in patients with polymyalgia rheumatica and giant cell arteritis during a 40-week follow-up
por: Emamifar, Amir, et al.
Publicado: (2021)

Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
por: Vogsen, Marianne, et al.
Publicado: (2021)

Prevalence of Newly Diagnosed Malignancies in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis, Comparison of 18F-FDG PET/CT Scan with Chest X-ray and Abdominal Ultrasound: Data from a 40 Week Prospective, Exploratory, Single Centre Study
por: Emamifar, Amir, et al.
Publicado: (2020)

An Overview of Interrater Agreement on Likert Scales for Researchers and Practitioners
por: O'Neill, Thomas A.
Publicado: (2017)

Bone Scintigraphy
por: Galasko, D.
Publicado: (1982)

Perspective of Patients With Metastatic Breast Cancer on Electronic Access to Scan Results: Mixed Methods Study
por: Baun, Christina, et al.
Publicado: (2020)

Assessing Agreement When Agreement Is Hard to Assess—The Agatston Score for Coronary Calcification
por: Andersen, Kristoffer Papsø, et al.
Publicado: (2022)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2023)

Chest Radiographs for Pediatric TB Diagnosis: Interrater Agreement and Utility
por: Kaguthi, G., et al.
Publicado: (2014)

Relationships between Contextual and Task Performance and Interrater Agreement: Are There Any?
por: Díaz-Vilela, Luis F., et al.
Publicado: (2015)

Prospective evaluation of interrater agreement between EEG technologists and neurophysiologists
por: Beuchat, Isabelle, et al.
Publicado: (2021)

Interrater agreement in classifying infections during extracorporeal membrane oxygenation
por: Verkerk, Karlijn, et al.
Publicado: (2023)

Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis: Is There Additional Value of Bone Scintigraphy with Blood Pool Phase over Conventional Bone Scintigraphy?
por: Kim, Ji Young, et al.
Publicado: (2016)

Interrater Agreement of an Arthroscopic Anterior Cruciate Ligament Tear Classification System
por: Vega, José F., et al.
Publicado: (2020)

Reporting Standards for a Bland–Altman Agreement Analysis: A Review of Methodological Reviews
por: Gerke, Oke
Publicado: (2020)

Nonparametric Limits of Agreement in Method Comparison Studies: A Simulation Study on Extreme Quantile Estimation
por: Gerke, Oke
Publicado: (2020)

Bone scintigraphy in osseous sarcoidosis
por: Cengiz, Arzu, et al.
Publicado: (2012)

Bone scintigraphy findings in calciphylaxis
por: Raduka, John, et al.
Publicado: (2018)

Bone scintigraphy in patients with pain
por: Shin, Seung Hyeon, et al.
Publicado: (2017)

Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
por: Al-Muqbel, Kusai M., et al.
Publicado: (2016)

Interrater agreement of the HEART score history component: A chart review study
por: Pawlukiewicz, Alec J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cn89g5hrppica794vv2tedcoa